SK&S advised Miura Partners on the deal. Miura Partners executed the acquisition of a majority stake in Meditrans by Proclinic and on the establishment of a strategic...
You must be a Standard 1 Year member to access this content.
O’Melveny & Myers LLP served as Semtech U.S. legal counsel and Stikeman Elliott LLP as its Canadian legal counsel. Davis Polk & Wardwell LLP served as...
You must be a Standard 1 Year member to access this content.
Fenwick represented Perceive Bio on the deal. Perceive Bio, a biotech company pioneering novel technologies and therapeutics in ophthalmology, announced its $78 million Series B financing. The...
You must be a Standard 1 Year member to access this content.
Viguié Schmidt & Associés, Deloitte Société d’Avocats and Deloitte Legal Italia have advised Orsero S.p.A. on the deal. Orsero S.p.A. has executed an agreement for the...
You must be a Standard 1 Year member to access this content.
Irwin Mitchell advised Saffron Cherry on the deal. Rainmaker Content, the international distributor that specialises in drama, factual and special-event programming, took a minority equity stake...
You must be a Standard 1 Year member to access this content.
YPOG and COMMEO advised the Vimcar shareholders on the deal, while White & Case advised Battery Ventures. Vimcar, a Berlin-based startup whose fleet management software and...
You must be a Standard 1 Year member to access this content.
McCarthy Tétrault advised SalonCentric and L’Oreal Canada Inc. on the acquisition. SalonCentric Canada, a subsidiary of L’Oréal, has acquired all assets in Canada of Alternative Beauty...
You must be a Standard 1 Year member to access this content.
Jia Yuan Law Offices advised Air China on the deal. Air China also announced its private placement of A shares on the same day, priced at...
You must be a Standard 1 Year member to access this content.
Tavarone, Rovelli, Salim & Miani acted as legal counsel on the transaction. San Cristóbal Servicios Financieros I financial trust executed its offering of $2.32 million notes. San...
You must be a Standard 1 Year member to access this content.
Fenwick represented Belharra Therapeutics on the deal. Belharra Therapeutics, a privately held drug discovery company with a novel photoaffinity-based, non-covalent chemoproteomics platform, announced its multi-year collaboration with...
You must be a Standard 1 Year member to access this content.
Viguié Schmidt & Associés and Gatti Pavesi Bianchi Ludovici advised Orsero S.p.A. The selling partners of Blampin SAS were advised by Fidal. Orsero S.p.A., an Italian...
You must be a Standard 1 Year member to access this content.
